According to the new market research report "Cannabis
Testing Market by Product & Software (LC, GC, Spectroscopy (MS, Atomic),
Column, Standards, Accessories, LIMS), Service (Potency, Pesticides, Heavy
Metal, Genetic Testing), End User (Lab, Pharmaceutical, Research) - Global
Forecast to 2021", published by MarketsandMarkets™, the overall cannabis
testing market expected to reach USD 1,416.3 million by 2021 from USD 822.0
million in 2016, at a CAGR of 11.5% of during the forecast period (2016-2021)
Don’t miss out on
business opportunities in Cannabis
Testing Market Size
Owing to various social and political factors, cannabis has
been banned in most countries since the early 1900s. At present, many countries
are increasingly recognizing the benefits of cannabis for medicinal purposes
and are hence approving its use.
Legalization fo
medical cannabis coupled with the growing number of cannabis testing
laboratories
Medical cannabis is proven to be effective in various
medical applications, such as reducing nausea caused due to chemotherapy,
stimulating appetite in AIDS patients, controlling muscular spasms in multiple
sclerosis patients, and reducing intraocular pressure in patients with
glaucoma. Owing to these potential health benefits, governments in various
countries are legalizing the use of medical cannabis. Countries including
Australia (2016), Canada (2015), North Korea, Spain, Portugal (2001), the U.K.
(2006), Germany (awaiting approval by the end of 2017), Italy, the Netherlands,
Israel, and Brazil have legalized the use of medical cannabis in recent years.
Moreover, in the U.S., 25 states have legalized medical cannabis; four states
Colorado, Washington, Oregon, and Alaska—have legalized cannabis for both
medical and recreational use.
Browse and in-depth
TOC on " Cannabis Testing
Market "
160 - Tables
49 - Figures
203 - Pages
Legalization fo
medical cannabis coupled with the growing number of cannabis testing
laboratories
Medical cannabis is proven to be effective in various
medical applications, such as reducing nausea caused due to chemotherapy,
stimulating appetite in AIDS patients, controlling muscular spasms in multiple
sclerosis patients, and reducing intraocular pressure in patients with glaucoma.
Owing to these potential health benefits, governments in various countries are
legalizing the use of medical cannabis. Countries including Australia (2016),
Canada (2015), North Korea, Spain, Portugal (2001), the U.K. (2006), Germany
(awaiting approval by the end of 2017), Italy, the Netherlands, Israel, and
Brazil have legalized the use of medical cannabis in recent years. Moreover, in
the U.S., 25 states have legalized medical cannabis; four states Colorado,
Washington, Oregon, and Alaska—have legalized cannabis for both medical and
recreational use.
To know about the
assumptions considered for the study, download
the pdf brochure
The following are the
major objectives of the study : Cannabis Testing Market
To define, describe, and forecast the global cannabis
testing market on the basis of product and software, service, end user, and
region
To provide detailed information regarding the major factors
influencing the growth of the market (drivers, restraints, opportunities, and
industry-specific challenges)
To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the overall
market
To analyze the opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
To forecast the market size of market segments with respect
to four main regions (along with the countries), namely, North America, Europe,
Asia-Pacific, and LATAM & MEA
To speak to our
analyst for a discussion on the above findings, click
Speak to Analyst
No comments:
Post a Comment